Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.


In the US, Mefoxin (cefoxitin systemic) is a member of the drug class second generation cephalosporins and is used to treat Aspiration Pneumonia, Bacterial Infection, Bone infection, Cesarean Section, Cholecystitis, Deep Neck Infection, Endometritis, Gonococcal Infection - Uncomplicated, Intraabdominal Infection, Joint Infection, Kidney Infections, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Septicemia, Skin and Structure Infection, Skin or Soft Tissue Infection, Surgical Prophylaxis and Urinary Tract Infection.

US matches:

Ingredient matches for Mefoxin


Cefoxitin is reported as an ingredient of Mefoxin in the following countries:

  • Lithuania

Cefoxitin sodium (a derivative of Cefoxitin) is reported as an ingredient of Mefoxin in the following countries:

  • Italy
  • Taiwan
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.